105 related articles for article (PubMed ID: 2539256)
1. Familial and iatrogenic cortisol receptor resistance.
Lamberts SW; Koper JW; Biemond P; den Holder FH; de Jong FH
Cancer Res; 1989 Apr; 49(8 Suppl):2217s-2219s. PubMed ID: 2539256
[TBL] [Abstract][Full Text] [Related]
2. Cortisol receptor resistance: the variability of its clinical presentation and response to treatment.
Lamberts SW; Koper JW; Biemond P; den Holder FH; de Jong FH
J Clin Endocrinol Metab; 1992 Feb; 74(2):313-21. PubMed ID: 1309833
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid resistance in humans and nonhuman primates.
Brandon DD; Markwick AJ; Chrousos GP; Loriaux DL
Cancer Res; 1989 Apr; 49(8 Suppl):2203s-2213s. PubMed ID: 2649236
[TBL] [Abstract][Full Text] [Related]
4. Familial and iatrogenic cortisol receptor resistance.
Lamberts SW; Koper JW; de Jong FH
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):385-8. PubMed ID: 1390287
[TBL] [Abstract][Full Text] [Related]
5. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs.
Selman PJ; Mol JA; Rutteman GR; van Garderen E; van den Ingh TS; Rijnberk A
J Reprod Fertil Suppl; 1997; 51():345-54. PubMed ID: 9404305
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach.
van Rossum EF; Lamberts SW
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):611-26. PubMed ID: 17161335
[TBL] [Abstract][Full Text] [Related]
7. Adrenal function under long-term raloxifene administration.
Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
[TBL] [Abstract][Full Text] [Related]
8. The endocrine effects of long-term treatment with mifepristone (RU 486).
Lamberts SW; Koper JW; de Jong FH
J Clin Endocrinol Metab; 1991 Jul; 73(1):187-91. PubMed ID: 1646217
[TBL] [Abstract][Full Text] [Related]
9. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
[TBL] [Abstract][Full Text] [Related]
10. The new steroid analog RU 486 inhibits glucocorticoid action in man.
Bertagna X; Bertagna C; Luton JP; Husson JM; Girard F
J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucocorticoid antagonism with RU 486 on pituitary-adrenal function in patients with major depression: time-dependent enhancement of plasma ACTH secretion.
Kling MA; Whitfield HJ; Brandt HA; Demitrack MA; Kalogeras K; Geracioti TD; Perini GI; Calabrese JR; Chrousos GP; Gold PW
Psychopharmacol Bull; 1989; 25(3):466-72. PubMed ID: 2560555
[TBL] [Abstract][Full Text] [Related]
12. Chronic prenatal ethanol exposure increases glucocorticoid-induced glutamate release in the hippocampus of the near-term foetal guinea pig.
Iqbal U; Brien JF; Kapoor A; Matthews SG; Reynolds JN
J Neuroendocrinol; 2006 Nov; 18(11):826-34. PubMed ID: 17026532
[TBL] [Abstract][Full Text] [Related]
13. Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene.
Huizenga NA; de Lange P; Koper JW; de Herder WW; Abs R; Kasteren JH; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 2000 May; 85(5):2076-81. PubMed ID: 10843199
[TBL] [Abstract][Full Text] [Related]
14. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
[TBL] [Abstract][Full Text] [Related]
15. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper.
Macedo JA; Hesse J; Turner JD; Meyer J; Hellhammer DH; Muller CP
Psychoneuroendocrinology; 2008 Jul; 33(6):799-809. PubMed ID: 18468809
[TBL] [Abstract][Full Text] [Related]
17. Familial cortisol resistance: differential diagnostic and therapeutic aspects.
Lamberts SW; Poldermans D; Zweens M; de Jong FH
J Clin Endocrinol Metab; 1986 Dec; 63(6):1328-33. PubMed ID: 3782421
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of skin fibroblasts from a patient with a new type of primary cortisol resistance: glucocorticoid receptor status and glucocorticoid effect on DNA synthesis.
Gomi M; Iida S; Tsugawa M; Itoh Y; Moriwaki K; Fujii H; Yamashita S; Tamaki T; Tarui S
Horm Metab Res; 1987 Jul; 19(7):328-30. PubMed ID: 3623423
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects.
Laue L; Lotze MT; Chrousos GP; Barnes K; Loriaux DL; Fleisher TA
J Clin Endocrinol Metab; 1990 Dec; 71(6):1474-80. PubMed ID: 2172280
[TBL] [Abstract][Full Text] [Related]
20. The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates.
Laue L; Gallucci W; Loriaux DL; Udelsman R; Chrousos GP
J Clin Endocrinol Metab; 1988 Sep; 67(3):602-6. PubMed ID: 2842364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
